Annual Total Liabilities
$53.18 M
+$23.97 M+82.04%
December 31, 2023
Summary
- As of February 7, 2025, LYRA annual total liabilities is $53.18 million, with the most recent change of +$23.97 million (+82.04%) on December 31, 2023.
- During the last 3 years, LYRA annual total liabilities has risen by +$46.84 million (+739.07%).
- LYRA annual total liabilities is now -61.55% below its all-time high of $138.30 million, reached on December 31, 2019.
Performance
LYRA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$58.14 M
-$5.47 M-8.60%
September 30, 2024
Summary
- As of February 7, 2025, LYRA quarterly total liabilities is $58.14 million, with the most recent change of -$5.47 million (-8.60%) on September 30, 2024.
- Over the past year, LYRA quarterly total liabilities has increased by +$21.80 million (+60.00%).
- LYRA quarterly total liabilities is now -65.30% below its all-time high of $167.55 million, reached on March 31, 2020.
Performance
LYRA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LYRA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.0% | +60.0% |
| 3 y3 years | +739.1% | +60.0% |
| 5 y5 years | -59.8% | +60.0% |
LYRA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +158.8% | -9.2% | +205.9% |
| 5 y | 5-year | -61.5% | +739.1% | -65.3% | +983.4% |
| alltime | all time | -61.5% | +739.1% | -65.3% | +983.4% |
Lyra Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $58.14 M(-8.6%) |
| Jun 2024 | - | $63.60 M(-0.7%) |
| Mar 2024 | - | $64.02 M(+20.4%) |
| Dec 2023 | $53.18 M(+82.0%) | $53.18 M(+46.4%) |
| Sep 2023 | - | $36.34 M(+34.1%) |
| Jun 2023 | - | $27.10 M(-2.4%) |
| Mar 2023 | - | $27.78 M(-4.9%) |
| Dec 2022 | $29.21 M | $29.21 M(+11.3%) |
| Sep 2022 | - | $26.24 M(+38.1%) |
| Jun 2022 | - | $19.00 M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $19.19 M(-6.6%) |
| Dec 2021 | $20.55 M(+224.3%) | $20.55 M(-0.1%) |
| Sep 2021 | - | $20.57 M(+9.2%) |
| Jun 2021 | - | $18.83 M(+251.0%) |
| Mar 2021 | - | $5.37 M(-15.3%) |
| Dec 2020 | $6.34 M(-95.4%) | $6.34 M(-1.2%) |
| Sep 2020 | - | $6.42 M(+8.7%) |
| Jun 2020 | - | $5.90 M(-96.5%) |
| Mar 2020 | - | $167.55 M(+21.1%) |
| Dec 2019 | $138.30 M(+4.4%) | $138.30 M |
| Dec 2018 | $132.43 M | - |
FAQ
- What is Lyra Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Lyra Therapeutics?
- What is Lyra Therapeutics annual total liabilities year-on-year change?
- What is Lyra Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly total liabilities year-on-year change?
What is Lyra Therapeutics annual total liabilities?
The current annual total liabilities of LYRA is $53.18 M
What is the all time high annual total liabilities for Lyra Therapeutics?
Lyra Therapeutics all-time high annual total liabilities is $138.30 M
What is Lyra Therapeutics annual total liabilities year-on-year change?
Over the past year, LYRA annual total liabilities has changed by +$23.97 M (+82.04%)
What is Lyra Therapeutics quarterly total liabilities?
The current quarterly total liabilities of LYRA is $58.14 M
What is the all time high quarterly total liabilities for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly total liabilities is $167.55 M
What is Lyra Therapeutics quarterly total liabilities year-on-year change?
Over the past year, LYRA quarterly total liabilities has changed by +$21.80 M (+60.00%)